• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center

Christopher A. French, MD

Associate Professor, Department of Pathology, Harvard Medical School

Associate Professor, Pathology, Brigham And Women's Hospital

Contact Info

Christopher French
Brigham and Women's Hospital
New Research Building, Rm. 630G

Boston, MA, 02115
Phone: 617-525-4415
Fax: 617-525-4422
cfrench@partners.org

Assistant

Muriel Goutas
Brigham And Women's Hospital
Phone: 617-525-4370
mgoutas@partners.org

DF/HCC Program Affiliation

Head and Neck Cancer

Research Abstract

Our focus is on the NUT midline carcinoma (NMC), an uncommon, but uniformly lethal disease defined by the presence of BRD-NUT fusion oncogene, either BRD4-NUT or BRD3-NUT. We have found that BRD-NUT blocks differentiation and maintains the growth of carcinoma cells in vitro and in vivo. What is not known is the mechanism by which this occurs. One goal of our lab is to identify the molecular mechanisms of BRD-NUT-induced oncogenesis. We are currently performing structure-function and protein-binding assays to map functional domains and identify proteins that interact with BRD-NUT. To this, we are using a differentiation assay in a BRD-NUT-expressing cell line that contains an interchangeable, isogenic, tetracycline-inducible transgene. The other goal of our lab is to identify molecules that interfere with the BRD-NUT pathway. We currently preparing to perform a drug screen on BRD-NUT carcinoma cells, using differentiation as the readout. The results of these studies should not only identify critical components of the BRD-NUT mechanism, but also provide potential novel targeted therapies to this disease.

Publications

View All Publications